Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Implications for employers: Although almost half of employers stated that they were interested in the potential for compounded GLP-1 medications, according to WTWs 2025 Best Practices in Healthcare Survey, only 7% said they were very interested, and there has been very little employer uptake of compounded medications
The peptide also appears to influence neurotransmitter systems, particularly the dopaminergic and GABAergic pathways, which may contribute to its observed effects on neurological function and behavior
I use it sparingly, but when I have a headache I put it on and it's one of my go-to tools
Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics
Symptoms can range from mild skin reactions, such as hives, to more severe symptoms, like difficulty breathing
Gureev AP, Chernyshova EV, Krutskikh EP, Sadovnikova IS, Tekutskaya EE, Dorohova AA
.png)
